Description： 2-Cycloproxyethanol belongs to the intermediate of besagliflozin and is used for the synthesis of besagliflozin. Its appearance is a colorless liquid with a total impurity of 1.6%, which meets the standard (less than or equal to 2%). Bexagliflozin is a strong and selective SGLT2 inhibitor. Bexagliflozin Brenzavvy is a drug for diabetes. It helps control blood sugar level by preventing the kidney from reabsorpting glucose. In addition, it can also help weight management and reduce cardiovascular risk, providing a new direction for comprehensive treatment of diabetes patients.